• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与微生物群相关的代谢物推动了对缺血性心脏病的认识。

Microbiota-related metabolites fueling the understanding of ischemic heart disease.

作者信息

Fan Yong, Ying Jiajun, Ma Hongchuang, Cui Hanbin

机构信息

Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province Ningbo China.

Department of Cardiology, Ningbo First Hospital Ningbo University Ningbo China.

出版信息

Imeta. 2023 Feb 26;2(2):e94. doi: 10.1002/imt2.94. eCollection 2023 May.

DOI:10.1002/imt2.94
PMID:38868424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10989774/
Abstract

Up-to-date knowledge of gut microbial taxa associated with ischemic heart disease (IHD). Microbial metabolites for mechanistic dissection of IHD pathology. Microbiome-based therapies in IHD prevention and treatment.

摘要

与缺血性心脏病（IHD）相关的肠道微生物分类群的最新知识。用于IHD病理机制剖析的微生物代谢产物。IHD预防和治疗中基于微生物群的疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/3378d40c2a4d/IMT2-2-e94-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/121e04a147c6/IMT2-2-e94-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/64baa083409c/IMT2-2-e94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/3378d40c2a4d/IMT2-2-e94-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/121e04a147c6/IMT2-2-e94-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/64baa083409c/IMT2-2-e94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c3/10989774/3378d40c2a4d/IMT2-2-e94-g004.jpg

相似文献

1
Microbiota-related metabolites fueling the understanding of ischemic heart disease.与微生物群相关的代谢物推动了对缺血性心脏病的认识。
Imeta. 2023 Feb 26;2(2):e94. doi: 10.1002/imt2.94. eCollection 2023 May.
2
Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus.地中海饮食中的精油对缺血性心脏病和 2 型糖尿病的肠道微生物群及其代谢产物的有益作用。
Nutrients. 2022 Nov 3;14(21):4650. doi: 10.3390/nu14214650.
3
Microbiome and metabolome features of the cardiometabolic disease spectrum.心血管代谢疾病谱的微生物组和代谢组特征。
Nat Med. 2022 Feb;28(2):303-314. doi: 10.1038/s41591-022-01688-4. Epub 2022 Feb 17.
4
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease.肠道微生物群及其代谢物：饮食营养素与阿尔茨海默病的桥梁。
Adv Nutr. 2023 Jul;14(4):819-839. doi: 10.1016/j.advnut.2023.04.005. Epub 2023 Apr 17.
5
A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations.肠道微生物组-代谢组关联的稳健性和普遍性的荟萃分析研究。
Microbiome. 2021 Oct 12;9(1):203. doi: 10.1186/s40168-021-01149-z.
6
Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.粪便代谢组和肠道微生物组之间的关键相互作用揭示了脑缺血性中风的功能特征。
J Transl Med. 2022 Oct 8;20(1):459. doi: 10.1186/s12967-022-03669-0.
7
Dissecting the causal links between gut microbiome, immune traits and polyp using genetic evidence.利用遗传证据剖析肠道微生物组、免疫特征和息肉之间的因果关系。
Front Immunol. 2024 Sep 13;15:1431990. doi: 10.3389/fimmu.2024.1431990. eCollection 2024.
8
New insight into gut microbiota and their metabolites in ischemic stroke: A promising therapeutic target.肠道微生物群及其代谢物在缺血性脑卒中的新认识：有希望的治疗靶点。
Biomed Pharmacother. 2023 Jun;162:114559. doi: 10.1016/j.biopha.2023.114559. Epub 2023 Mar 28.
9
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.阿尔茨海默病中肠道微生物群-小胶质细胞-脑的相互作用：基于知识的多维度表征
Alzheimers Res Ther. 2021 Oct 20;13(1):177. doi: 10.1186/s13195-021-00917-1.
10
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword.中风中的肠道微生物群及其代谢产物：一把双刃剑
Stroke. 2022 May;53(5):1788-1801. doi: 10.1161/STROKEAHA.121.036800. Epub 2022 Feb 9.

引用本文的文献

1
The mechanism of Guanxin Qiwei dropping pills target to improve atherosclerosis.冠心七味滴丸改善动脉粥样硬化的作用机制。
Front Pharmacol. 2025 Jul 1;16:1633862. doi: 10.3389/fphar.2025.1633862. eCollection 2025.
2
Gut microbiome related to metabolic diseases after moderate-to-vigorous intensity exercise.中度至剧烈强度运动后与代谢疾病相关的肠道微生物群。
J Exerc Sci Fit. 2024 Oct;22(4):375-382. doi: 10.1016/j.jesf.2024.07.003. Epub 2024 Jul 25.
3
Visualizing set relationships: EVenn's comprehensive approach to Venn diagrams.

本文引用的文献

1
Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease.两种不同的肠道微生物途径共同导致苯乙酰谷氨酰胺的代谢产物生成，这与心血管疾病有关。
Cell Host Microbe. 2023 Jan 11;31(1):18-32.e9. doi: 10.1016/j.chom.2022.11.015. Epub 2022 Dec 21.
2
Drivers and determinants of strain dynamics following fecal microbiota transplantation.粪便微生物群移植后菌株动态的驱动因素和决定因素。
Nat Med. 2022 Sep;28(9):1902-1912. doi: 10.1038/s41591-022-01913-0. Epub 2022 Sep 15.
3
Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy.
可视化集合关系：EVenn对维恩图的全面方法。
Imeta. 2024 Apr 11;3(3):e184. doi: 10.1002/imt2.184. eCollection 2024 Jun.
4
Gut microbiota in heart failure and related interventions.心力衰竭中的肠道微生物群及相关干预措施。
Imeta. 2023 Jul 10;2(3):e125. doi: 10.1002/imt2.125. eCollection 2023 Aug.
5
The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.肠道微生物群在自身免疫性肝炎发病机制中的意义：叙述性综述。
Front Cell Infect Microbiol. 2024 Feb 9;14:1337223. doi: 10.3389/fcimb.2024.1337223. eCollection 2024.
6
Recent Advances in Microbiota-Associated Metabolites in Heart Failure.心力衰竭中微生物群相关代谢产物的最新进展
Biomedicines. 2023 Aug 21;11(8):2313. doi: 10.3390/biomedicines11082313.
肠道微生物群产生的三甲基-5-氨基戊酸会减少脂肪酸氧化并加速心脏肥大。
Nat Commun. 2022 Apr 1;13(1):1757. doi: 10.1038/s41467-022-29060-7.
4
Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation.硫酸吲哚酚和对甲酚诱导的单核细胞黏附和迁移是由整合素连接激酶依赖性的足突形成介导的。
Exp Mol Med. 2022 Mar;54(3):226-238. doi: 10.1038/s12276-022-00738-8. Epub 2022 Mar 4.
5
Microbiome and metabolome features of the cardiometabolic disease spectrum.心血管代谢疾病谱的微生物组和代谢组特征。
Nat Med. 2022 Feb;28(2):303-314. doi: 10.1038/s41591-022-01688-4. Epub 2022 Feb 17.
6
Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.代谢组学和微生物组分析揭示冠状动脉疾病的个性化风险因素。
Nat Med. 2022 Feb;28(2):295-302. doi: 10.1038/s41591-022-01686-6. Epub 2022 Feb 17.
7
Indoxyl sulfate in uremia: an old idea with updated concepts.尿毒症中的硫酸吲哚酚：一个具有更新概念的老观点。
J Clin Invest. 2022 Jan 4;132(1). doi: 10.1172/JCI155860.
8
The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism.微生物 gbu 基因簇将与食用红色肉类相关的心血管疾病风险与微生物组 L-肉碱代谢联系起来。
Nat Microbiol. 2022 Jan;7(1):73-86. doi: 10.1038/s41564-021-01010-x. Epub 2021 Dec 23.
9
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy.肠道代谢物氧化三甲胺与动脉粥样硬化：从机制到治疗
Front Cardiovasc Med. 2021 Nov 23;8:723886. doi: 10.3389/fcvm.2021.723886. eCollection 2021.
10
Characterization of gut microbial structural variations as determinants of human bile acid metabolism.肠道微生物结构变化特征可作为人类胆汁酸代谢的决定因素。
Cell Host Microbe. 2021 Dec 8;29(12):1802-1814.e5. doi: 10.1016/j.chom.2021.11.003. Epub 2021 Nov 29.